IBOV 172,236.05 ▲ 2.22% IPC MEX 72,104.80 ▲ 1.00% MERVAL 2,848,945 — — USD/BRL5.51▲ 0.04% USD/MXN18.53▼ 0.53% USD/CLP966.96▼ 0.99% USD/COP3,269▲ 0.88% USD/PEN3.41▼ 1.07% USD/ARS1,545▼ 0.02% USD/UYU40.45▲ 0.35% USD/PYG6,450▲ 1.45% USD/BOB11.74▼ 0.59% USD/DOP60.40▼ 0.31% USD/CRC446.56▼ 0.38% USD/GTQ7.64▼ 0.05% USD/HNL26.89▲ 0.02% USD/NIO 36.62 — 0.00% USD/VES897.02▲ 0.07% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.79▼ 0.02% USD/TTD6.72▼ 0.03% EUR/BRL6.18▲ 0.86% BRENT 92.53 ▼ 5.89% WTI 86.68 ▼ 4.57% IRON ORE 161.91 — — COPPER 6.36 ▲ 2.34% GOLD 4,132 ▲ 1.40% SILVER 53.08 ▲ 2.46% SOY 1,187 ▼ 0.17% CORN 438.75 ▼ 0.62% WHEAT 587.50 ▼ 0.63% COFFEE 266.70 ▼ 4.75% SUGAR 18.21 ▼ 0.16% ORANGE JUICE 143.50 ▲ 7.85% COTTON 78.65 ▼ 0.58% COCOA 5,113 ▼ 0.81% BEEF 216.33 ▲ 1.06% CATTLE 324.80 ▲ 0.77% LITHIUM 61.35 ▲ 1.94% PETR4 45.19 ▼ 0.24% VALE3 66.11 ▲ 3.23% ITUB4 41.72 ▲ 2.94% BBDC4 14.68 ▲ 3.38% ABEV3 15.61 ▲ 0.84% BBAS3 17.02 ▼ 0.64% B3SA3 14.85 ▲ 3.20% WEGE3 50.74 ▲ 5.29% PRIO3 59.39 ▼ 1.80% SUZB3 54.20 ▲ 1.50% RENT3 30.83 ▲ 1.78% AZZA3 15.12 ▲ 2.44% CSAN3 2.77 — 0.00% RAIZ4 28.00 ▲ 2.56% PCAR3 2.43 ▲ 1.25% GMAT3 3.83 ▲ 0.79% PSSA3 45.65 ▲ 2.93% CVCB3 0.87 ▲ 3.57% POSI3 3.03 ▼ 1.94% SLCE3 17.30 ▲ 4.15% NATU3 5.71 ▲ 10.44% BRKM5 3.02 ▼ 5.63% RANI3 8.76 ▲ 3.44% CSNA3 4.49 ▲ 1.81% IBOV 172,236.05 ▲ 2.22% IPC MEX 72,104.80 ▲ 1.00% MERVAL 2,848,945 — — USD/BRL 5.51 ▲ 0.04% USD/MXN 18.53 ▼ 0.52% USD/CLP 966.96 ▼ 0.99% USD/COP 3,269 ▲ 0.88% USD/PEN 3.41 ▼ 1.07% USD/ARS 1,545 ▼ 0.02% USD/UYU 40.45 ▲ 0.35% USD/PYG 6,450 ▲ 1.45% USD/BOB 11.74 ▼ 0.59% USD/DOP 60.40 ▼ 0.31% USD/CRC 446.56 ▼ 0.38% USD/GTQ 7.64 ▼ 0.05% USD/HNL 26.89 ▲ 0.02% USD/NIO 36.62 — 0.00% USD/VES 897.02 ▲ 0.07% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.79 ▲ 2.64% USD/TTD 6.72 ▲ 2.40% EUR/BRL 6.18 ▲ 0.86% BRENT 92.53 ▼ 5.89% WTI 86.68 ▼ 4.57% IRON ORE 161.91 — — COPPER 6.36 ▲ 2.34% GOLD 4,132 ▲ 1.40% SILVER 53.08 ▲ 2.46% SOY 1,187 ▼ 0.17% CORN 438.75 ▼ 0.62% WHEAT 587.50 ▼ 0.63% COFFEE 266.70 ▼ 4.75% SUGAR 18.21 ▼ 0.16% ORANGE JUICE 143.50 ▲ 7.85% COTTON 78.65 ▼ 0.58% COCOA 5,113 ▼ 0.81% BEEF 216.33 ▲ 1.06% CATTLE 324.80 ▲ 0.77% LITHIUM 61.35 ▲ 1.94% PETR4 45.19 ▼ 0.24% VALE3 66.11 ▲ 3.23% ITUB4 41.72 ▲ 2.94% BBDC4 14.68 ▲ 3.38% ABEV3 15.61 ▲ 0.84% BBAS3 17.02 ▼ 0.64% B3SA3 14.85 ▲ 3.20% WEGE3 50.74 ▲ 5.29% PRIO3 59.39 ▼ 1.80% SUZB3 54.20 ▲ 1.50% RENT3 30.83 ▲ 1.78% AZZA3 15.12 ▲ 2.44% CSAN3 2.77 — 0.00% RAIZ4 28.00 ▲ 2.56% PCAR3 2.43 ▲ 1.25% GMAT3 3.83 ▲ 0.79% PSSA3 45.65 ▲ 2.93% CVCB3 0.87 ▲ 3.57% POSI3 3.03 ▼ 1.94% SLCE3 17.30 ▲ 4.15% NATU3 5.71 ▲ 10.44% BRKM5 3.02 ▼ 5.63% RANI3 8.76 ▲ 3.44% CSNA3 4.49 ▲ 1.81%
since 2009
Tuesday, November 10, 2026

J&J helped fund study in the 1970s in which U.S. prisoners were injected with asbestos.

By · · 2 min read

RIO DE JANEIRO, BRAZIL – U.S. pharmaceutical giant Johnson & Johnson (J&J) allegedly helped fund an experiment at a Pennsylvania prison in the 1970s in which several mostly African-American inmates were injected with asbestos, a group of minerals linked to lung cancer, to determine whether the substance was safe for use in talc manufactured by the company.

According to documents released by Bloomberg on Monday, the company participated in the controversial testing by Dr. Albert Kligman, a University of Pennsylvania dermatologist whose human trials have been widely condemned as brutal and unethical.

To conduct the experiment, Kligman recruited ten inmates from Holmesburg Prison in 1971 to inject them with tremolite and chrysotile asbestos, along with an injection of talcum powder into their lower backs. As a reward for their participation, each inmate received between US$10 and US$300.

Free daily brief — no card needed
Get every Crypto story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.
J&J headquarters.
J&J headquarters.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

However, many of the volunteers were seriously injured and suffered side effects. One of them was called a “monster” by his daughter because he suffered deformities as a result of the tests.

COMPANY AT THE CENTER OF CONTROVERSY

While the experiments were public knowledge and linked to the U.S. government and chemical company Dow, this is the first time Johnson & Johnson’s involvement has come to light.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Trump says deportations "might be too tough"”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

“We deeply regret the conditions under which these studies were conducted, and they in no way reflect the values or practices we employ today,” a spokesperson for the drugmaker said.

J&J also faces thousands of lawsuits after allegations surfaced that some of its products containing talc are often contaminated with asbestos and pose a risk to consumers.

To deal with the allegations, the company formed a corporation last October, which was immediately declared insolvent, to take on the brunt of the litigation over its baby powder.

The legal maneuver dubbed a “two-stage Texas bankruptcy,” is intended to transfer any liabilities J&J might face as a result of lawsuits or other legal action to the new structure.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Read More from The Rio Times

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.